The European Centre for Connected Health reports that there is a growing volume of evidence in the field of telemedicine. Evidence from the literature is strongest for the use of home telemonitoring in the management of chronic disease, in particular the monitoring of vital signs.
The evidence base is not without weaknesses and some of the main criticism of the current evidence is the lack of studies of large size and the relatively short duration of a number of the interventions. To date there has been insufficient economic appraisal of telemedicine interventions.
The evidence base is relatively strong in favour of the use of remote telemonitoring in diabetes mellitus, chronic heart failure and to a lesser extent for chronic obstructive pulmonary disease. Benefits offered from remote telemonitoring reported from this review are:
• Patient acceptance and satisfaction with remote telemonitoring
• Health Professional acceptance
• Reduction of chronic disease complications
• Improvement in patients quality of life to include reduction in days spent in hospital and travel time associated with appointments for patients
• Improvement in patient self management and education
• Patient empowerment
• Significant reduction in mortality associated with chronic heart failure
• Reduction in acute hospital admissions and rehospitalisation episodes
Draft Report June 2008
Posts
0 kommentarer:
Post a Comment